Headache Center

For over ten years, we have been conducting the "Stop the Headache" program, developed by Heide Denecke and Birgit Kröner-Herwig, in an outpatient setting in close cooperation with Techniker Krankenkasse (a German health insurance company). Building on this, we developed a [...]

On May 2, 2019, the Federal Joint Committee (G-BA) adopted the benefit assessment of erenumab in accordance with Section 35a of the German Social Code, Book V (SGB V). A considerable additional benefit was derived from the submitted data only for adult patients, which did not [...]

The third edition of the International Classification of Headache Disorders (ICHD-3) is now available digitally in German. The digital ICHD-3 makes it much easier to understand the structure and content of the current classification. The practical [...]

What role do triggers play in migraines? The word trigger means trigger. It's like a gun. When you press the trigger, the shot goes off. A small event triggers a complex process. The [...]

According to today's knowledge, the migraine pain is based on a neurogenic inflammatory reaction on the arteries of the brain skin. Inflammatory substances are released there in the initial stage of the migraine attack. These lead to an increased sensitivity to pain of the brain skin with swelling and expansion [...]

Accompanying word for the book by Dr. Martin Leonhard: "Success factors of my Kiel Migraine case" Headache are the people's disease No. 1, headache from the tension type and migraines are the most common neurological diseases of humans. Within a year are in [...]

According to Erenumab (Aimovig®) on November 1, 2018, the second antibody Galcanezumab (EMGALITY®) will also be available for migraine prophylaxis in Germany on April 1, 2019. Galcanezumab has been approved in the EU since November 2018. The [...]

 Kiel, February 4, 2019. Technician health insurance (TK), together with the University Hospital Schleswig-Holstein (UKSH) and the Pain Clinic Kiel, is launching digital discharge management. In the future, TK insured persons will receive their discharge report immediately after a hospital stay [...]

Successful as prophylaxis when other drug therapies are exhausted with Erenumab in November 2018 the first medication of a new class for the prophylaxis of migraines on the German market. In an early benefit assessment, [...]

How often do migraines appear in children? 73.9 percent of seventh graders complain about primary headaches. The most common forms are migraines and headache from the tension type. Almost 50 % of those affected report symptoms of migraines [...]

The migraines worldwide behind Zahnkaries and headache from the type of voltage occupies the 3rd place of the most common diseases of humans [28]. The one-year prevalence in Europe for all forms of migraines is 43.6% in women and 26.9% [...]

. Germany's academic offspring are struggling headaches. Around 1.8 of the 2.8 million students in Germany suffer. Almost every third of them are seriously impaired by headaches. That is the highest severity [...]

The pain clinic Kiel is the new partner of the growing, cross -carrier quality network "We für Health". The network includes more than 220 selected partner clinics and a variety of outpatient facilities across Germany, the above-average treatment and service quality [...]

The 3rd edition of the international classification of headache diseases (IchD-3) is now also available in its final form in the German translation. It can be viewed on the homepage of the IchD-3 via the link https://www.ichd-3.org/ichd-3-translations/. Particularly [...]